XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
TDCC Consolidated Statements of Cash Flows Statement - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net income $ 3,993 $ 4,644
Depreciation and amortization 2,104 2,187
Provision for deferred income tax 124 488
Earnings of nonconsolidated affiliates less than (in excess of) dividends received 517 (519)
Net periodic pension benefit cost 19 34
Pension contributions (156) (1,166)
Net gain on sales of assets, businesses and investments (11) (67)
Restructuring and asset related charges - net 186 22
Other net loss 159 874
Accounts and notes receivable 323 (2,222)
Inventories (254) (1,502)
Accounts payable (860) 1,487
Other assets and liabilities, net (736) 252
Cash provided by operating activities 5,397 4,434
Capital expenditures (1,224) (1,035)
Investment in gas field developments (134) (44)
Purchases of previously leased assets (5) (5)
Proceeds from sales of property and businesses, net of cash divested 16 15
Acquisitions of property and businesses, net of cash acquired (54) (107)
Investments in and loans to nonconsolidated affiliates (69) 0
Distributions and loan repayments from nonconsolidated affiliates 10 11
Proceeds from sales of ownership interests in nonconsolidated affiliates 11 0
Purchases of investments (445) (1,004)
Proceeds from sales and maturities of investments 596 644
Other investing activities, net (41) (10)
Cash used for investing activities (1,339) (1,535)
Changes in short-term notes payable 72 (44)
Proceeds from issuance of short-term debt greater than three months 0 144
Payments on short-term debt greater than three months (14) 0
Proceeds from issuance of long-term debt 82 95
Payments on long-term debt (957) (2,638)
Proceeds from issuance of stock 99 212
Transaction financing, debt issuance and other costs (8) (536)
Employee taxes paid for share-based payment arrangements (34) (11)
Distributions to noncontrolling interests (42) (35)
Dividends paid to stockholders (1,511) (1,561)
Cash used for financing activities (4,513) (4,974)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (261) (57)
Decrease in cash, cash equivalents and restricted cash (716) (2,132)
Cash, cash equivalents and restricted cash at beginning of period 3,033 5,108
Cash, cash equivalents and restricted cash at end of period 2,317 2,976
Less: Restricted cash and cash equivalents, included in "Other current assets" 101 65
Cash and cash equivalents and end of period 2,216 2,911
The Dow Chemical Company    
Net income 3,999 4,645
Depreciation and amortization 2,104 2,187
Provision for deferred income tax 125 488
Earnings of nonconsolidated affiliates less than (in excess of) dividends received 517 (519)
Net periodic pension benefit cost 19 34
Pension contributions (156) (1,166)
Net gain on sales of assets, businesses and investments (11) (67)
Restructuring and asset related charges - net 186 22
Other net loss 167 878
Accounts and notes receivable 323 (2,222)
Inventories (254) (1,502)
Accounts payable (860) 1,487
Other assets and liabilities, net (718) 369
Cash provided by operating activities 5,441 4,634
Capital expenditures (1,224) (1,035)
Investment in gas field developments (134) (44)
Purchases of previously leased assets (5) (5)
Proceeds from sales of property and businesses, net of cash divested 16 15
Acquisitions of property and businesses, net of cash acquired (54) (107)
Investments in and loans to nonconsolidated affiliates (69) 0
Distributions and loan repayments from nonconsolidated affiliates 10 11
Proceeds from sales of ownership interests in nonconsolidated affiliates 11 0
Purchases of investments (445) (1,004)
Proceeds from sales and maturities of investments 596 644
Other investing activities, net (41) (10)
Cash used for investing activities (1,339) (1,535)
Changes in short-term notes payable 72 (44)
Proceeds from issuance of short-term debt greater than three months 0 144
Payments on short-term debt greater than three months (14) 0
Proceeds from issuance of long-term debt 82 95
Payments on long-term debt (957) (2,638)
Proceeds from issuance of stock 99 212
Transaction financing, debt issuance and other costs (8) (536)
Employee taxes paid for share-based payment arrangements (34) (11)
Distributions to noncontrolling interests (42) (35)
Dividends paid to stockholders (3,755) (2,361)
Cash used for financing activities (4,557) (5,174)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (261) (57)
Decrease in cash, cash equivalents and restricted cash (716) (2,132)
Cash, cash equivalents and restricted cash at beginning of period 3,033 5,108
Cash, cash equivalents and restricted cash at end of period 2,317 2,976
Less: Restricted cash and cash equivalents, included in "Other current assets" 101 65
Cash and cash equivalents and end of period $ 2,216 $ 2,911